Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Topper James N
Relationship:  
City:   Seattle
State:   WA
   
Insider Summary:
  
   
Companies Owned :   14    
Direct Shares   20,715,944    

Indirect Shares

   33,777,420      
Direct Value   $192,205,825    

Indirect Value

   $517,243,818      
Total Shares   54,493,364      
Total Value   $709,449,643      


Anaptysbio Inc $1,934,639 Alpine Immune Sciences Inc $96,422,952 Mirum Pharmaceuticals, Inc. $0 Arcutis Biotherapeutics, Inc. $88,137,724 Passage Bio, Inc. $5,710,510 Phathom Pharmaceuticals, Inc. $0 Anaptysbio Inc $1,934,639 Alpine Immune Sciences Inc $96,422,952 Mirum Pharmaceuticals, Inc. $0 Arcutis Biotherapeutics, Inc. $88,137,724 Passage Bio, Inc. $5,710,510 Phathom Pharmaceuticals, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    3   
    1    

     Stock price went up :
    0   
    1    
     Stock price went down :
    3   
    0    
   
     Gain/Loss Ratio :
   -3.0   
   1.0   
     Percentage Gain/Loss :
   -17.1%
 0.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            La Jolla Pharmaceutical Co LJPC Director 2005-12-14 0 2009-02-26 0    Premium*  
            Amicus Therapeutics Inc FOLD Director, 10% Owner 2007-06-05 0 2008-03-10 3,520,678    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2013-05-28 0 2013-05-28 1,428,954    Premium*  
            Sierra Oncology Inc SRRA Director, 10% Owner 2015-07-21 0 2017-02-14 8,112,121    Premium*  
            Anaptysbio Inc ANAB Director 2020-11-16 80,812 2020-11-16 199,529    Premium*  
            Alpine Immune Sciences Inc ALPN Director 2022-02-11 1,484,115 2024-05-18 0    Premium*  
            Allena Pharmaceuticals, Inc. ALNA Director, 10% Owner 2017-11-06 0 2017-11-06 3,330,373    Premium*  
            Aptinyx Inc. APTX Director 2018-06-25 0 2020-03-31 3,195,055    Premium*  
            Entasis Therapeutics Holdings Inc. ETTX Director, 10% Owner 2018-09-28 0 2018-09-28 1,349,953    Premium*  
            Mirum Pharmaceuticals, Inc. MIRM 10% Owner 2019-07-22 3,566,912 2019-07-22 0    Premium*  
            Arcutis Biotherapeutics, Inc. ARQT 10% Owner 2020-02-04 10,542,790 0    Premium*  
            Passage Bio, Inc. PASG 10% Owner 2020-03-03 5,009,219 2020-03-03 0    Premium*  
            Phathom Pharmaceuticals, Inc. PHAT 2024-05-23 32,096 2024-05-23 5,831,328    Premium*  
            Newamsterdam Pharma Ord Shs NAMS 0 2024-03-26 6,809,429    Premium*  
* Premium Members only  

Records found :    95         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-12 4 B $9.99 $94,213 I/I 9,400 617,667 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-13 4 B $10.44 $60,799 I/I 5,800 629,667 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-13 4 B $10.10 $64,025 I/I 6,200 623,867 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-15 4 B $10.47 $72,439 I/I 6,900 636,567 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-19 4 B $9.74 $95,015 I/I 9,600 646,167 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-20 4 B $9.50 $476,019 I/I 49,500 695,667 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-21 4 B $9.86 $56,254 I/I 5,500 701,167 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-22 4 B $9.67 $65,218 I/I 6,614 709,781 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-22 4 B $10.09 $2,019 I/I 200 709,981 2.17 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-22 4 B $9.53 $19,197 I/I 2,000 703,167 2.17 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-25 4 B $9.45 $93,680 I/I 9,700 719,681 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-26 4 B $9.49 $59,252 I/I 6,100 725,781 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-26 4 B $9.99 $19,323 I/I 1,900 727,681 2.17 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-27 4 B $9.95 $86,480 I/I 8,600 750,981 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-27 4 B $9.65 $143,616 I/I 14,700 742,381 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-28 4 B $9.84 $20,195 I/I 2,038 753,019 2.17 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-28 4 B $9.97 $58,068 I/I 5,762 758,781 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-02-29 4 B $9.63 $85,356 I/I 8,637 767,418 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-03-03 4 B $9.83 $24,720,612 I/I 18,426 829,518 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-03-03 4 B $9.51 $422,230 I/I 43,674 811,092 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-03-04 4 B $9.85 $89,869 I/I 9,000 843,018 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-03-04 4 B $9.60 $43,719 I/I 4,500 834,018 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-03-05 4 B $9.76 $371,681 I/I 37,992 893,018 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-03-05 4 B $9.64 $116,133 I/I 12,008 855,026 2.25 -
FOLD Amicus Therapeutics Inc Director   –       •       •   2008-03-06 4 B $9.90 $221,723 I/I 22,146 915,164 2.25 -
  95  Records found
  1   2   3  4      
  Page 3 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us